Stock Price Quote

GLAND PHARMA LTD.

NSE : GLANDBSE : 543245ISIN CODE : INE068V01023Industry : Pharmaceuticals & DrugsHouse : Private
BSE1726.659.35 (+0.54 %)
PREV CLOSE ( ) 1717.30
OPEN PRICE ( ) 1720.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 10401
TODAY'S LOW / HIGH ( )1709.25 1732.10
52 WK LOW / HIGH ( )1660 4060
NSE1726.6511.05 (+0.64 %)
PREV CLOSE( ) 1715.60
OPEN PRICE ( ) 1726.90
BID PRICE (QTY) 1726.65 (97)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 190619
TODAY'S LOW / HIGH( ) 1708.00 1732.20
52 WK LOW / HIGH ( )1660 4062.95
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 20-03 1978
Management Info
Yiu Kwan Stanley Lau - Chairman Srinivas Sadu - Managing Director
Registered Office

Address Survey No. 143-148, 150 & 151,Near Gandimaisamma 'x' Roads, D. P. Pally,Dundigal Gandimaisamma Mandal, Medchal-malkajgiri District,
Hyderabad,
Telangana-500043

Phone 040 30510999

Email gland@glandpharma.com/investor@glandpharma.com

Website www.glandpharma.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE

NEWS

05Dec Gland Pharma informs about analyst meet
Pursuant to Regulation 30 read with Part A of the Securities and Exchang..
30Nov Gland Pharma enters into put option ag
Gland Pharma through its wholly owned subsidiary -- Gland Pharma Interna..
29Nov Reply For The Clarification Sought On
Reply for the clarification sought on news item appearing in "Media / Pu..
29Nov Announcement under Regulation 30 (LOD
Press Release on the Proposed Acquisition of Cenexi Group
24Nov Gland Pharma informs about analyst mee
Pursuant to Regulation 30 read with Part A of the Securities and Exchang..

Financials

in Millions
QTR Sep 22 ANNUAL 22
Net Profit2396.312121.55
Gross Profit 3224.7 16190.43
Operating Profit 3608.5917345.79
Net Sales 10483.0944007.08

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Sanofi India (BSE)
peergroup  5881.15 (2.80%)
M.Cap ( in Cr)13544.65
Dr. Reddy's Lab (BSE)
peergroup  4408.00 (1.21%)
M.Cap ( in Cr)73393.25
Alkem Laboratories (BSE)
peergroup  3138.60 (1.52%)
M.Cap ( in Cr)37526.67
Abbott India (BSE)
peergroup  20408.65 (0.18%)
M.Cap ( in Cr)43366.96
Jubilant Pharmova (BSE)
peergroup  407.65 (5.31%)
M.Cap ( in Cr)6493.10

Shareholding Pattern

PROMOTERS 57.86%
FI/BANKS/INSURANCE 2.1%
MUTUAL FUNDS/UTI 18.48%
NON-INSTITUTION 14.13%
GOVERNMENT 0%
FII 0%

About Gland Pharma Ltd.

Gland Pharma Ltd. was incorporated in the year 1978. Its today's share price is 1726.65. Its current market capitalisation stands at Rs 28436.24 Cr. In the latest quarter, company has reported Gross Sales of Rs. 44007.08 Cr and Total Income of Rs.46246.48 Cr. The company's management includes Allen Zhang, Yao Fang, Qiyu Chen, Essaji Goolam Vahanvati, Satyanarayana Murthy Chavali, Udo Jahannes Vetter, Naina Lal Kidwai, Srinivas Sadu, Yiu Kwan Stanley Lau, P Sampath Kumar.

It is listed on the BSE with a BSE Code of 543245 , NSE with an NSE Symbol of GLAND and ISIN of INE068V01023. It's Registered office is at Survey No. 143-148, 150 & 151,Near Gandimaisamma 'x' Roads, D. P. Pally,Dundigal Gandimaisamma Mandal, Medchal-malkajgiri DistrictHyderabad-500043, Telangana. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are SR Batliboi & Associates LLP, SR Batliboi & Associates, LLP, Y Raghuram & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)